Roux-en-Y Gastric Bypass Compared to Glucagon-Like Peptide-1 Receptor Agonists is Associated with Lower Out-of-Pocket Costs in Insured Patients with Type 2 Diabetes and Obesity: A Matched Analysis Over Two Years. - Thiyagarajan S; Wall-Wieler E; Liu Y; Zheng F; Edwards M (Obesity surgery, 2026)